
End-of-dose deterioration in non ergolinic dopamine agonist monotherapy of Parkinson’s disease
Astrid Thomas, Laura Bonanni, Angelo Di Iorio, Sara Varanese, Francesca Anzellotti, Anna D’Andreagiovanni, Fabrizio Stocchi, Marco OnofrjVolume:
253
Langue:
english
Pages:
7
DOI:
10.1007/s00415-006-0320-z
Date:
December, 2006
Fichier:
PDF, 113 KB
english, 2006